Who has invested in IFM Therapeutics?

Omega Funds, Atlas Venture, Abingworth are named among the investors backing IFM Therapeutics.

IFM Therapeutics Funding: $56M Raised, Investors & Rounds

IFM Therapeutics funding overview

IFM Therapeutics is based in Boston. IFM Therapeutics has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for IFM Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Omega Funds, Atlas Venture, Abingworth. 3 distinct backers are named across the disclosed rounds.

IFM Therapeutics at a glance

Total raised: $56M
Latest round date: December 2019
Headquarters: Boston
Notable investors: Omega Funds, Atlas Venture, Abingworth

Frequently asked about IFM Therapeutics funding

How much has IFM Therapeutics raised?: IFM Therapeutics has raised $56M in total disclosed funding across the rounds on record.
Who has invested in IFM Therapeutics?: Omega Funds, Atlas Venture, Abingworth are named among the investors backing IFM Therapeutics.
What was the latest IFM Therapeutics funding round?: No round stage has been disclosed for IFM Therapeutics.
Where is IFM Therapeutics based?: IFM Therapeutics is based in Boston.
When did IFM Therapeutics last raise?: The last disclosed IFM Therapeutics round closed in December 2019.

Round data for IFM Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.

IFM Therapeutics Funding: $56M Raised, Investors & Rounds

IFM Therapeutics funding overview

IFM Therapeutics at a glance

Frequently asked about IFM Therapeutics funding

Companies related to IFM Therapeutics (36)

Browse related funding lists (7)